QCI Interpret for Oncology
Rapid, evidence-based reporting of oncology NGS tests at scale
148 views
Connected to the world’s most comprehensive, manually curated knowledge base that is updated weekly, QCI Interpret One dynamically computes variant classifications according to AMP/ASCO/CAP and ACMG/AMP guidelines with full transparency. Users get access to over 200,000 pre-formulated, oncologist-reviewed variant interpretation summaries and can build customizable, oncologist-ready reports with the latest diagnostic and prognostic information, as well as biomarker-directed therapies and clinical trials.
In this webinar, attendees will learn:
How QCI Interpret One computes variant classifications
How simple it is to submit variants for professional interpretation via the software
How QCI Interpret One eliminates the need for variant curation
How users can generate customizable, oncologist-ready reports according to AMP/ASCO/CAP guidelines for therapeutic, prognostic, and diagnostic actionability
Speakers:
Beate Litzenburger, PhD
Global Product Director of Oncology
QIAGEN Digital Insights
Sheryl Elkin, PhD
Chief Scientific Officer
N-of-One, a QIAGEN company
Related videos
QCI Interpret for Oncology
Expert insights to advance NGS oncology profiling
Recently, GenomeWeb and Qiagen partnered on a survey that allowed...
QCI Interpret for Oncology
QCI Interpret One: Oncology variant interpretation just got more precise
Competing to offer a comprehensive genomic profiling service for solid or...
QCI Interpret for Oncology
Reduce your test turnaround for large cancer panels
Speaker: Sheryl Elkin, CSO, QDI, QIAGEN Interested in learning more? Click here
QCI Interpret for Oncology
Gaining insights with transcriptomic profiling and mechanistic modeling
In this webinar, Moritz Schütte, head of next-generation sequencing data...